Linzagolix found effective in reducing severe menstrual bleeding: Lancet Jacinthlyn Sylvia27 Sept 2022 7:30 PM ISTUSA: A new study conducted by Jacques Donnez and colleagues found that linzagolix (100 mg or 200 mg) effectively decreased severe menstrual bleeding...
Catheter-based renal artery denervation shows long-term positive outcomes for resistant hypertension: SYMPLICITY HTN-3 Trial Medha Baranwal26 Sept 2022 6:15 PM ISTUSA: The Renal Denervation in Patients With Uncontrolled Hypertension -- SYMPLICITY HTN-3 trial demonstrated the safety of the Symplicity system but...
Relugolix combo treatment may reduce opioid use in endometriosis-related discomfort Jacinthlyn Sylvia20 Sept 2022 8:00 PM ISTUSA: Relugolix combo treatment taken once a day reduced endometriosis-related discomfort and was well tolerated by patients, says an article published...
Combination treatment provides more pain relief than monotherapy in diabetic neuropathy: Lancet Medha Baranwal19 Sept 2022 9:15 AM ISTUK: Diabetic peripheral neuropathic pain (DPNP) is characterized by tingling, burning, shooting, sharp, and lancinating or electric shock sensations...
Infants, young children finally get relief from eczema's terrible itch Isra Zaman17 Sept 2022 9:30 AM ISTThe first study to treat moderate-to-severe eczema in infants and children 6 months to 5 years old with a biologic drug rather than...
Monoclonal antibody mepolizumab reduces asthma exacerbations among urban youth: Lancet Dr. Kamal Kant Kohli15 Sept 2022 11:30 AM ISTResearchers have found in a National Institutes of Health clinical trial that Monoclonal antibody mepolizumab, reduces asthma exacerbations among...
Rising public health concerns on antibiotic overuse in India: The Lancet Aditi13 Sept 2022 3:56 PM ISTAntibiotic resistance is a global health concern, making curing many infections expensive and impossible. The unwise use of antibiotics is driving...
Early Methotrexate initiation before patients develop rheumatism provides lasting relief: Lancet Dr. Kamal Kant Kohli15 Aug 2022 8:00 PM ISTEarly treatment benefits patients who have not fully developed rheumatoid arthritis but are in the preliminary stages of the disease. This is what...
FDA approves combination Therapy for pain due to Endometriosis Dr. Kamal Kant Kohli9 Aug 2022 7:30 PM ISTThe US Food and Drug Administration (FDA) has approved combination therapy containing relugolix, estradiol, and norethindrone acetate (Myfembree) for...
Weight loss: Endoscopic sleeve gastroplasty effective option for obese patients: Lancet Dr. Hiral patel8 Aug 2022 7:30 PM ISTUSA: A new study in The Lancet found that endoscopic sleeve gastroplasty (ESG) is a safe intervention leading to significant weight loss and...
Pfizer, Myovant Sciences get USFDA nod for MYFEMBREE Ruchika Sharma7 Aug 2022 11:30 AM ISTMYFEMBREE offers an effective, once-daily treatment option for the management of moderate to severe pain associated with endometriosis, with a...
Lancet study provides insights of most effective pharmacologic treatment for insomnia disorder Medha Baranwal29 July 2022 8:00 PM ISTUK: A recent study in The Lancet comparing the effectivness of pharmacological treatments for the acute and long-term treatment of adults with...
